Souhaitez-vous accéder aux communiqués récents ?

      The Programs Are Expected to Benefit up to 500,000 Patients in Northeast Pennsylvania and Reduce Cost of Care by $100 Million LEHIGH VALLEY, Pa. and DUBLIN - February 28, 2018 - Today,...

FDA Approved, Resolute Onyx 2.0 mm DES Technology Tackles Clinical Challenge of Treating Coronary Artery Disease in Previously Untreatable Patients DUBLIN - February 26, 2018 - Designed...

DUBLIN- February 26, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has approved a new arm indication for...

New Infusion Set Offers Simpler, Faster, and More Convenient1 Insulin Pump Experience DUBLIN - February 21, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, services and...

Revenue of $7.4 Billion Increased 1% as Reported; 7% at Comparable, Constant Currency  GAAP Diluted LPS of $1.03; Non-GAAP Diluted EPS of $1.17 Company Reiterates Full Year Revenue and EPS...

DUBLIN - February 16, 2018 - Medtronic plc  (NYSE:MDT), the global leader in medical technology, today announced it will participate in the CECP CEO Investor Forum 3.0 in New York on Monday,...

DUBLIN and VIENNA - February 15, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that new data from its at-home pediatric study of the MiniMed(TM) 670G...

DUBLIN - February 13, 2018 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the third quarter of fiscal year 2018 on Tuesday, February 20, 2018. A news release...

Medtronic Will Host an Exclusive Symposium on Thursday, February 15 VIENNA - February 13, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its schedule of...

DUBLIN and SHANGHAI - January 30, 2018 - Medtronic plc (NYSE:MDT) today announced that Alex Gu, previously Vice President, Regional Growth Initiatives, Greater China, and leader of Medtronic's...